schizandrin b has been researched along with interleukin-8 in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, S; Lin, Q; Meng, Y; Qin, X; Qin, Z; Shi, M | 1 |
1 other study(ies) available for schizandrin b and interleukin-8
| Article | Year |
|---|---|
Schisandrin B inhibits LPS-induced inflammatory response in human umbilical vein endothelial cells by activating Nrf2.
Topics: Anti-Inflammatory Agents; Cyclooctanes; Endothelium, Vascular; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-8; Lignans; Lipopolysaccharides; NF-E2-Related Factor 2; NF-kappa B; Polycyclic Compounds; RNA, Small Interfering; Schisandra; Signal Transduction; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2017 |